返回 Agenda
Session Chair(s)
Jose C. Pinheiro, PHD
Head of Statistical Modeling and Methodology, SDS
Janssen Research & Development, LLC, United States
H. M. James Hung, PHD
Director, Division of Biometrics I, Office of Biostatistics, OTS, CDER
FDA, United States
Speaker(s)
Characterizing Dose-Response in the development of Novel Treatments for Multiple Sclerosis
David Ohlssen, PHD
Novartis Pharmaceuticals Corporation, United States
Senior Expert Methodologist
Discussants
Neal Thomas, PHD
Pfizer Inc, United States
Executive Director, Biostatistics
Sue-Jane Wang, PHD, MA, MS
FDA, United States
Mathematician Statistician
Frank Bretz, PHD
Novartis , Switzerland
Distinguished Quantitative Research Scientist
H. M. James Hung, PHD
FDA, United States
Director, Division of Biometrics I, Office of Biostatistics, OTS, CDER